Ankylosing spondylitis: open trials in Canada

3 open trials have a site in Canada. Registry data; only the trial team decides who can take part.

NCT06668181
An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
Trial Treatment · Phase 3 · UCB Biopharma SRL
Ja0005 50646, Calgary · Ja0005 50644, Montreal · Ja0005 50645, Saskatoon
Registry updated 2026-10-23
NCT07133633
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC
G.R.M.O. (Groupe de recherche en maladies osseuses) Inc. ( Site 0200), Québec · Toronto Western Hospital ( Site 0205), Toronto · Centre de Recherche Musculo-Squelettique ( Site 0202), Trois-Rivières
Registry updated 2026-10-23
NCT05603728
Exactech Shoulder Post Market Clinical Follow-up Study
Research · Exactech
St. Joseph's Health Care, London
Registry updated 2026-09-17

This page is not medical advice. Talk to your doctor before contacting a trial.

An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis